• ABL Diagnostics will attend Investor Access @ Maison de la Chimie Paris 2026 on Oct. 6-7, 2026.
• Management plans one-to-one meetings with professional investors during the Paris event.
• Discussions will cover recent developments, growth strategy, outlook, international expansion, molecular diagnostics positioning.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260917898340) on September 17, 2026, and is solely responsible for the information contained therein.